Arkolith/Insider Trading/NUTX/Form 4

Vo Thomas T.

Chief Executive Officer, DirectorNutex Health, Inc. (NUTX) · full profile →Form 4 · filed May 30, 2024
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 30, 2024Buy(P)3K$0.66$2K18.1M
May 29, 2024Buy(P)4K$0.68$3K18.1M
May 28, 2024Buy(P)48K$0.70$34K18.1M
May 13, 2024Buy(P)17K$0.69$12K18.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001486189-24-000027) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML